Site Search
Professionals 204 results
Capabilities 64 results
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Practice Area
Class Actions & Group Litigation
Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence.
Practice Area
White Collar & Government Investigations
Ranked Tier 1 Nationally for “Criminal Defense: White Collar” by Best Law Firms® 2025, and recognized for “Corporate Crime & Investigations: Highly Regarded – Nationwide” by Chambers USA in 2025, Winston’s White Collar & Government Investigations Practice assists individuals, companies, and organizations with government investigations and enforcement matters; related criminal and civil litigation; trials; appeals; congressional oversight; internal investigations; and compliance counseling and program development and enhancement. We are comprised of 80+ litigators, with more than a dozen former prosecutors from the SEC, Main Justice, and U.S. Attorneys’ Offices nationwide, including three former U.S. Attorneys, Regional Supervisors, and a former Chief of IRS Criminal Investigation. We are known for our zealous advocacy, our unyielding commitment to our clients, and for protecting and defending clients’ interests with legal acumen that’s second to none.
Experience 12 results
Experience
|June 28, 2024
Agreement Between 119 Institutional Investors and the Company Vivendi SE
119 institutional investors, among which Union Asset Management Holding, accused the French company Vivendi of having disseminated false or misleading information between 2000 and 2002, thereby causing them an important stock market damage.
Experience
|May 10, 2024
Winston’s London Restructuring practice scores a significant win on appeal for Hong Kong and BVI liquidator claimants in the People’s Republic of China (PRC) based Peking University Founders Group Limited (PUFG) insolvency.
Insights & News 388 results
In the Media
|July 2, 2025
|2 Min Read
Jonathan Levine Joins Winston & Strawn in New York
Winston & Strawn recently announced the addition of Jonathan Levine to the firm’s New York office as a partner in the Transactions Department and a member of the Restructuring Practice. Jonathan counsels clients on a wide range of corporate matters, with a focus on complex corporate restructurings both in court and out of court. His clients include distressed companies, direct lenders, ad hoc groups, sponsors, asset managers, hedge funds and other strategic investors.
Article
|June 18, 2025
|1 Min Read
Chambers Blockchain 2025 Global Practice Guide: Trends and Developments
This article was originally published in Chambers and Partners Global Practice Guide “Blockchain 2025.” Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Article
|June 16, 2025
|1 Min Read
Chambers Healthcare M&A 2025 Global Practice Guide - France
This article was originally published in Chambers and Partners Global Practice Guide “Healthcare M&A 2025.” Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Other Results 20 results
Location
Opened in 2003, Winston & Strawn’s San Francisco office is located in the financial district, just down the road from the Bay Area’s technology epicenter. Our team—now 25+ lawyers strong—keeps a finger on the pulse of the rapidly evolving financial services and technology sectors, and offers support across a wide spectrum of services, including antitrust/competition, commercial litigation and disputes, government investigations and compliance, intellectual property, labor and employment, mergers and acquisitions, and product liability. The San Francisco team works seamlessly with lawyers and departments across the firm’s global network to ensure the highest quality service to our clients. With a culture that represents the Bay Area’s innovative spirit, our lawyers are regularly honored with high-profile awards and frequently recognized by publications, such as Chambers USA, The American Lawyer, the Daily Journal, and The Recorder.
Location
Winston & Strawn’s São Paulo office reflects the firm’s long-term investment in Brazil and the significant commitment of Winston’s Latin America practice group members to the country over many decades. Our fully bilingual São Paulo-based attorneys represent clients on international financing, cross-border mergers and acquisitions, corporate governance, and disputes. They also act as a relationship touch point for global clients looking to expand into Brazil, ensuring an integrated and seamless service. Our São Paulo attorneys have in-depth knowledge of the region’s legal, cultural, political, regulatory, and commercial frameworks, which have earned them recognition from Chambers Global, Chambers Brazil, Chambers Latin America, Leaders League, The Legal 500, Latinvex, IFLR 1000, and LatinFinance, among many others.
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.